Disclosure Of Intangible Assets [Text Block]

Zealand Pharma - Filing #1417063

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
Disclosure of intangible assets [text block]
Disclosure of detailed information about intangible assets [text block]
Disclosure of detailed information about intangible assets [abstract]
Disclosure of detailed information about intangible assets [line items]
Reconciliation of changes in intangible assets other than goodwill [abstract]
Intangible assets other than goodwill
53,790,000 DKK
57,485,000 DKK
Research and development expense
588,453,000 DKK
604,081,000 DKK
561,423,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.